Trials / Completed
CompletedNCT05892991
Using Different Amplitude-modulated Frequencies of IFC for the Treatment of Trigger Points
Influence of Using Different Amplitude Modulated Frequencies on the Effectiveness of Interferential Current in Treating Trapezius Trigger Points: a Randomized Controlled Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- University of Hail · Academic / Other
- Sex
- All
- Age
- 17 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
the authors of this work will conduct a randomized controlled trial intended to examine different amplitude-modulated frequencies of interferential current on different measures related to chronic trigger points located in the upper trapezius muscle.
Detailed description
this randomized controlled trial was designed to fill a gap in the literature regarding the most effective amplitude-modulated frequency of interferential current on pain pressure threshold, cervical ROM, and function of the neck region. this study will be consisted of 4 groups, all groups will receive standard manual treatment commonly used for the treatment of chronic trigger points. this treatment will be conducted 3 times per week for 4 weeks. The standard treatment will consist of an intermittent neuromuscular inhibition technique. the 3 experimental groups will receive interferential current sessions (3/week) for 4 weeks with the same parameters except for the amplitude-modulated frequency. outcome measurements will be assessed at baseline, at 4 weeks, and at 4 weeks of the end of the treatment (follow-up).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | interferential current | this intervention is a type of therapeutic electrical currents of medium frequency used commonly in physical therapy to relieve acute and chronic pain as well as stimulate muscle contraction. |
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2024-07-30
- Completion
- 2024-08-01
- First posted
- 2023-06-07
- Last updated
- 2025-01-07
Locations
2 sites across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT05892991. Inclusion in this directory is not an endorsement.